Enochian Biosciences, Inc. (ENOB)

NASDAQ: ENOB · IEX Real-Time Price · USD
0.930
0.00 (0.00%)
Mar 31, 2023, 11:49 AM EDT - Market open
Market Cap 51.81M
Revenue (ttm) n/a
Net Income (ttm) -108.60M
Shares Out 55.71M
EPS (ttm) -2.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,452
Open 0.950
Previous Close 0.930
Day's Range 0.920 - 0.980
52-Week Range 0.900 - 8.880
Beta 1.12
Analysts n/a
Price Target n/a
Earnings Date Apr 3, 2023

About ENOB

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Eric Leire
Employees 11
Stock Exchange NASDAQ
Ticker Symbol ENOB
Full Company Profile

Financial Performance

Financial Statements

News

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the “Company”) announces that Dr. Anahid Jewett, a renowned cancer researcher in the field of immunotherapy f...

2 days ago - GlobeNewsWire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

LOS ANGELES, March 13, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB). Enochian BioSciences Inc. (the Company) announced that it has achieved full compliance with NASDAQ filing requirements. The Annual Repor...

2 weeks ago - GlobeNewsWire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

LOS ANGELES, Feb. 23, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- On February 16, 2023, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nas...

1 month ago - GlobeNewsWire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- On November 23, 2022, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nas...

4 months ago - GlobeNewsWire

Enochian BioSciences Forges Ahead With Focused Approach, Promising Future

LOS ANGELES, Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—Enochian BioSciences (the Company) recently announced significant progress toward re-prioritizing its focus on curing some of the world's ...

5 months ago - GlobeNewsWire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

LOS ANGELES, Oct. 21, 2022 (GLOBE NEWSWIRE) -- On October 17, 2022, Enochian BioSciences, Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that...

5 months ago - GlobeNewsWire

Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer

5 months ago - GlobeNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Enochian BioSciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 26, 2022 - (NASDAQ: ENOB)

NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Enochian BioSciences, Inc..

6 months ago - PRNewsWire

ENOB FINAL DEADLINE TODAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB

New York, New York--(Newsfile Corp. - September 26, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) be...

6 months ago - Newsfile Corp

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...

6 months ago - Newsfile Corp

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 26, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of inve...

6 months ago - Business Wire

Bronstein, Gewirtz & Grossman, LLC Reminds Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm

New York, New York--(Newsfile Corp. - September 23, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Enochian Biosciences Inc.

6 months ago - Newsfile Corp

MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 23, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...

6 months ago - Newsfile Corp

ENOB SHAREHOLDER ALERT: Jakubowitz Law Reminds Enochian Shareholders of a Lead Plaintiff Deadline of September 26, 2022

NEW YORK , Sept. 23, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Enochian BioSciences, Inc. (NASDAQ: ENOB).

6 months ago - PRNewsWire

Enochian Class Action: Levi & Korsinsky Reminds Enochian BioSciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 26, 2022 - ENOB

New York, New York--(Newsfile Corp. - September 22, 2022) - Levi & Korsinsky, LLP notifies investors in Enochian BioSciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB) of a class action securi...

6 months ago - Newsfile Corp

MONDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 22, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...

6 months ago - Newsfile Corp

ENOB LAWSUIT ALERT: Levi & Korsinsky Notifies Enochian BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Sept. 22, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Enochian BioSciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB) of a class action securities lawsuit.

6 months ago - PRNewsWire

ENOB Investors Have Opportunity to Lead Enochian Biosciences, Inc. Securities Fraud Lawsuit

BENSALEM, Pa. , Sept. 20, 2022 /PRNewswire/ -- Law Offices of Howard G.

6 months ago - PRNewsWire

ENOB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 26, 2022 in the Class Action Filed on Behalf of Enochian BioSciences, Inc. Shareholders

NEW YORK , Sept. 20, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Enochian BioSciences, Inc. (NASDAQ: ENOB) alleging that...

6 months ago - PRNewsWire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Enochian Investors of a Lead Plaintiff Deadline of September 26, 2022

NEW YORK , Sept. 19, 2022 /PRNewswire/ -- Attention Enochian BioSciences, Inc. ("Enochian") (NASDAQ: ENOB) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commen...

6 months ago - PRNewsWire

ENOB FINAL DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB

NEW YORK , Sept. 17, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enochian BioSciences, Inc. (NASDAQ: ENOB) between January 17, ...

6 months ago - PRNewsWire

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - ENOB

New York, New York--(Newsfile Corp. - September 17, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. ("Enochian" or the "Company") (NASDAQ: ...

6 months ago - Newsfile Corp

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 15, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...

7 months ago - Newsfile Corp

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 14, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosci...

7 months ago - Newsfile Corp

ENOB LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Enochian BioSciences, Inc.

New York, New York--(Newsfile Corp. - September 13, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Enochian BioS...

7 months ago - Newsfile Corp